In compliance with current regulations, let us know which audience you belong to:
Onto
the Retina
Discover the revolutionary
LM® Low-level Light Therapy!
Join Dr. Claudio Iovino, MD, as he presents preliminary results from the LightWave I clinical trial, unveiling the potential of photobiomodulation (PBM) in AMD management.
He explores the risk factors associated with AMD progression and highlights promising results of Light Modulation® LLLT (photobiomodulation therapy ), showcasing improvements in visual acuity and reduction of drusen volume without causing atrophy.
Join us on this enlightening journey in advancing eye care and explore the transformative possibilities of photobiomodulation.
—Ophthalmology Scientific Compendium
Learn more about our research efforts in AMD management and dive deeper on Light Modulation® LLLT (PBM).
Access our Scientific Compendium, a comprehensive review of our latest publications in Ophthalmology.
